Urinary Extracellular Vesicle Signatures as Biomarkers in Prostate Cancer Patients
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26146895 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Sigrun Lange und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pathobiology and Extracellular Vesicles Research Group, School of Life Sciences, University of Westminster, London W1W 6UW, UK. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Extracellular Vesicles, Biomarkers, Tumor. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: London Metropolitan University.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Urinary extracellular vesicles (U-EVs) are gaining increasing interest as non-invasive liquid biopsy tools for clinical use. Prostate cancer (PCa) is amongst the highest cancer-related cause of death in men, and therefore, the identification of non-invasive robust biomarkers is of high importance. This study assessed U-EV profiles from individuals affected by PCa at Gleason scores 6–9, compared with healthy controls. U-EVs were characterised and assessed for proteomic cargo content by LC-MS/MS analysis. The U-EV proteomes were compared for enrichment of gene ontology (GO), KEGG, and Reactome pathways, as well as disease–gene associations. U-EVs ranged in size from 50 to 350 nm, with the majority falling within the 100–200 nm size range for all groups. U-EV protein cargoes from the PCa groups differed significantly from healthy controls, with 16 protein hits unique to the GS 6–7 and 88 hits to the GS 8–9 U-EVs. Pathway analysis showed increased enrichment in the PCa U-EVs of biological process GO (5 and 37 unique to GS 6–7 and GS 8–9, respectively), molecular function GO (3 and 6 unique to GS 6–7 and GS 8–9, respectively), and cellular component GO (10 and 22 unique to GS 6–7 and GS 8–9, respectively) pathways. A similar increase was seen for KEGG pathways (11 unique to GS 8–9) and Reactome pathways (102 unique to GS 8–9). Enrichment of disease–gene associations was also increased in the PCa U-EVs, with highest differences for the GS 8–9 U-EVs (26 unique terms). The pathway enrichment in the PCa U-EVs was related to several key inflammatory, cell differentiation, cell adhesion, oestrogen signalling, and infection pathways. Unique GO and KEGG pathways enriched for the GS 8–9 U-EVs were associated with cell–cell communication, immune and stress responses, apoptosis, peptidase activity, antioxidant activity, platelet aggregation, mitosis, proteasome, mRNA stability oxytocin signalling, cardiomyopathy, and several neurodegenerative diseases. Our findings highlight U-EVs as biomarkers to inform disease pathways in prostate cancer patients and offer a non-invasive biomarker tool for clinical use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pathobiology and Extracellular Vesicles Research Group, School of Life Sciences, University of Westminster, London W1W 6UW, UK.
- Hertfordshire and Bedfordshire Urological Cancer Centre, Department of Urology, Lister Hospital, East and North Hertfordshire Teaching NHS Trust, Stevenage, Hertfordshire SG1 4AB, UK.
- Department of Engineering and Technology, School of Physics, Engineering & Computer Science, University of Hertfordshire, Hatfield AL10 9EU, UK.
- Electron Microscopy Suite, Faculty of Science, Technology, Engineering and Mathematics, Open University, Milton Keynes MK7 6AA, UK.
- UKRI: Science & Technology Facilities Council, Central Laser Facility, Rutherford Appleton Laboratory, Oxfordshire OX11 0QX, UK.
- School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9EU, UK.
ORCID-Profile: Sigrun Lange, Darryl Ethan Bernstein, Nikolay Dimov, Ian Johnston, Igor Kraev, Sarah R Needham, Nikhil Vasdev, Jameel M Inal
Förderung
- London Metropolitan University
Zitieren
APA
Lange, S., Bernstein, D. E., Dimov, N., Puttaswamy, S., Johnston, I., Kraev, I., Needham, S. R., Vasdev, N., & Inal, J. M. (2025). Urinary Extracellular Vesicle Signatures as Biomarkers in Prostate Cancer Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26146895
Vancouver
Lange S, Bernstein DE, Dimov N, Puttaswamy S, Johnston I, Kraev I, et al. Urinary Extracellular Vesicle Signatures as Biomarkers in Prostate Cancer Patients. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26146895
BibTeX
@article{Lange2025,
author = {Lange, Sigrun and Bernstein, Darryl Ethan and Dimov, Nikolay and Puttaswamy, Srinivasu and Johnston, Ian and Kraev, Igor and Needham, Sarah R and Vasdev, Nikhil and Inal, Jameel M},
title = {Urinary Extracellular Vesicle Signatures as Biomarkers in Prostate Cancer Patients},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26146895}
}
EUVIMED